Table 1.
Baseline patient characteristics
| Placebo (N = 111) | Etoricoxib (N = 108) | Celecoxib (N = 107) | Ibuprofen (N = 107) | |
|---|---|---|---|---|
| Mean age (SD) (years) | 57.8 (10.1) | 59.3 (10.6) | 59.3 (10.3) | 56.8 (10.2) |
| Sex [n, (%)] | ||||
| Women | 75 (67.6) | 68 (63.0) | 64 (59.8) | 62 (57.9) |
| Current tobacco user [n, (%)] | 19 (17.1) | 14 (13.0) | 11 (10.3) | 18 (16.8) |
| History of [n, (%)] | ||||
| Diabetes | 6 (5.4) | 4 (3.7) | 4 (3.7) | 3 (2.8) |
| Hypertension | 48 (43.2) | 48 (44.4) | 39 (36.4) | 43 (40.2) |
| Hypercholesterolemia | 20 (18.0) | 19 (17.6) | 18 (16.8) | 20 (18.7) |
| Framingham Risk Score >Median (6) [n, (%)] | 39 (35.1) | 42 (38.9) | 44 (41.1) | 41 (38.3) |